Earnings
Sight Sciences Raises Dry Eye Outlook To About $12 Million, Calls The Bar Deliberately Low
Executives told analysts the TearCare forecast reflects an early market, after a question on a roughly 6% fourth-quarter slowdown.
SGHT
Sight Sciences (SGHT) news from Bullished: SEC filings, earnings, insider trades and deals, explained in plain English with links to the source documents.
SEC Filings
Sight Sciences Gets Six More Months Of Interest-Only Payments On Its $40.0 Million Hercules Loan
A fourth amendment moves the start of repayment to August 1, 2027, and most of the debt stays long-term on the balance sheet.
Earnings
Sight Sciences Raises 2026 Revenue Outlook To $92 Million-$93 Million As Dry Eye Sales Jump
The eye-care device maker's third-quarter revenue rose 25% to a record, and cash burn fell 74% to $2.4 million.